T1	Treatment 0 3	PSK
T2	Treatment 130 229	oral adjuvant immunochemotherapy with protein-bound polysaccharide K (PSK) and tegafur/uracil (UFT)
T3	Treatment 309 319	UFT alone.
T4	Treatment 320 323	PSK
T5	Treatment 553 556	PSK
T6	Treatment 882 913	PSK plus 300 mg UFT (PSK group)
T7	Treatment 924 933	UFT alone
T8	Treatment 1136 1139	PSK
T9	Treatment 1172 1185	control group
T10	Treatment 1498 1501	PSK
T11	Treatment 1938 1947	PSK + UFT
T12	Treatment 2116 2119	PSK
